Please use this identifier to cite or link to this item:
http://localhost:80/xmlui/handle/123456789/14892
Title: | Cross-sectional study of zero-medicine markup policy, prescribing trends and drug indicators using WHO/INRUD methodology in Chinese Jingzhou area |
Authors: | Jun, Zou Jingsong, Mei Guohua, Jia Yuanrong, Yang |
Keywords: | Cross-sectional study markup policy pharmacoepidemiology rational use of drugs economic data drug indicator prescribing trend antibiotic percent injection percent |
Issue Date: | 20-Jul-2022 |
Publisher: | Karachi:Pakistan Journal of Pharmaceutical Sciences, university of Karachi. |
Citation: | Jun, Z., Jingsong, M., Guohua, J., & Yuanrong, Y. (2022). Cross-sectional study of zero-medicine markup policy, prescribing trends and drug indicators using WHO/INRUD methodology in Chinese Jingzhou area. Pakistan Journal of Pharmaceutical Sciences, 35(4). |
Abstract: | In order to get the baseline data of Chinese Zero-Medicine Markup Policy, before any administrative intervention we investigated the drug indicators, the prescribing trends and economic data. In accordance with the WHO/INRUD criteria and cross-sectional studies, the retrospective methods along with equal sample interval of systematic sampling were used. We sampled from daily prescriptions and calculated the means over a twelve day period. We sampled from 38,246 adult prescriptions, the sampling percent was 3.06%, and the drugs prescribed by generic name were 100.00%. During 2012-2014, the percentage of antibiotic cost in the total daily drug cost decreased from17.44% to 8.01%, the percentage of prescriptions with antibiotic prescribed decreased from 12.64% to 9.64%, the percentage of encounters with an injection prescribed decreased from 15.21% to 12.77%. The average drug cost per antibiotic prescription ranged from ¥169.33 to 186.66. By comparing the related data, Zero-Medicine Markup Policy had greatly affected prescribing indicators, some indicators had a decreasing trend and became more rational, Zero-Markup Medicine Policy decreased both the patient-level and hospital-level drug expenses, and the reformation of the ZeroMedicine Markup Policy was steadily advanced. |
URI: | http://142.54.178.187:9060/xmlui/handle/123456789/14892 |
ISSN: | 1011-601X |
Appears in Collections: | Issue No.4 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
3-10194.htm | 131 B | HTML | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.